Skip to content

Drug interactions

Belatacept + Cladribine

Severity: Major

Belatacept and Cladribine: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Cladribine depletes lymphocytes and belatacept blocks T-cell costimulation. Combined use increases the risk of serious infections and possibly malignancy such as post-transplant lymphoproliferative disorder.

What this interaction means in plain words

Belatacept and Cladribine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Belatacept belongs to Miscellaneous; Cladribine belongs to Oncology.

Evidence level: Moderate

Why it happens

Additive immunosuppression through lymphocyte depletion and T-cell costimulation blockade.

What to do

Avoid the combination where possible, as oral cladribine labeling advises against concurrent immunosuppressants. If used, monitor lymphocyte counts and screen closely for infection.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Belatacept and Cladribine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Belatacept with Cladribine?

MediHelp rates the interaction as major. Belatacept and Cladribine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Cladribine depletes lymphocytes and belatacept blocks T-cell costimulation. Combined use increases the risk of serious infections and possibly malignancy such as post-transplant lymphoproliferative disorder.

How serious is the interaction between Belatacept and Cladribine?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination where possible, as oral cladribine labeling advises against concurrent immunosuppressants. If used, monitor lymphocyte counts and screen closely for infection.

What other medicines interact with Cladribine?

MediHelp also lists interactions of Cladribine with, for example, Adenovirus types 4 and 7 live, Siponimod, Tofacitinib. The full list is on the Cladribine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in